iShares Dow Jones US Medical Dev. (IHI) Shares Bought by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. boosted its stake in shares of iShares Dow Jones US Medical Dev. (BMV:IHI) by 41.5% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 39,869 shares of the company’s stock after acquiring an additional 11,687 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in iShares Dow Jones US Medical Dev. were worth $9,231,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Gerber Kawasaki Wealth & Investment Management boosted its stake in shares of iShares Dow Jones US Medical Dev. by 27.0% in the first quarter. Gerber Kawasaki Wealth & Investment Management now owns 13,740 shares of the company’s stock valued at $3,181,000 after purchasing an additional 2,920 shares during the period. Outlook Wealth Advisors LLC purchased a new position in shares of iShares Dow Jones US Medical Dev. in the first quarter valued at approximately $1,206,000. Kovack Advisors Inc. boosted its stake in shares of iShares Dow Jones US Medical Dev. by 26.2% in the first quarter. Kovack Advisors Inc. now owns 3,425 shares of the company’s stock valued at $793,000 after purchasing an additional 710 shares during the period. Moloney Securities Asset Management LLC boosted its stake in shares of iShares Dow Jones US Medical Dev. by 278.3% in the first quarter. Moloney Securities Asset Management LLC now owns 4,892 shares of the company’s stock valued at $1,133,000 after purchasing an additional 3,599 shares during the period. Finally, Advisors Preferred LLC purchased a new position in shares of iShares Dow Jones US Medical Dev. in the first quarter valued at approximately $255,000.

BMV IHI opened at $220.94 on Friday. iShares Dow Jones US Medical Dev. has a one year low of $2,806.59 and a one year high of $3,563.30.

TRADEMARK VIOLATION WARNING: “iShares Dow Jones US Medical Dev. (IHI) Shares Bought by Cambridge Investment Research Advisors Inc.” was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/24/ishares-dow-jones-us-medical-dev-ihi-shares-bought-by-cambridge-investment-research-advisors-inc.html.

Featured Article: Stock Split

Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Dow Jones US Medical Dev. (BMV:IHI).

Institutional Ownership by Quarter for iShares Dow Jones US Medical Dev. (BMV:IHI)

Receive News & Ratings for iShares Dow Jones US Medical Dev. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Dow Jones US Medical Dev. and related companies with MarketBeat.com's FREE daily email newsletter.